| __timestamp | ACADIA Pharmaceuticals Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 120000 | 9757000 |
| Thursday, January 1, 2015 | 61000 | 1253000 |
| Friday, January 1, 2016 | 17331000 | 5421000 |
| Sunday, January 1, 2017 | 124901000 | 154584000 |
| Monday, January 1, 2018 | 223807000 | 301034000 |
| Tuesday, January 1, 2019 | 339076000 | 380833000 |
| Wednesday, January 1, 2020 | 441755000 | 540099000 |
| Friday, January 1, 2021 | 484145000 | 701887000 |
| Saturday, January 1, 2022 | 517235000 | 933013000 |
| Sunday, January 1, 2023 | 726437000 | 1243336000 |
Cracking the code
In the competitive world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc. have shown remarkable trajectories. Starting in 2014, Sarepta's revenue was nearly 81 times that of ACADIA, but both companies have experienced significant growth since then. By 2023, Sarepta's revenue surged to approximately 1.24 billion, marking a tenfold increase, while ACADIA's revenue grew to 726 million, a staggering 12,000-fold increase from its 2015 low. This growth reflects the companies' strategic advancements in their respective therapeutic areas. Sarepta's focus on genetic medicine and ACADIA's dedication to central nervous system disorders have propelled them to the forefront of the biotech industry. As these companies continue to innovate, their revenue trends offer a glimpse into the future of biotechnology.
Novartis AG vs ACADIA Pharmaceuticals Inc.: Examining Key Revenue Metrics
Bristol-Myers Squibb Company vs ACADIA Pharmaceuticals Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Sarepta Therapeutics, Inc.
Breaking Down Revenue Trends: argenx SE vs Sarepta Therapeutics, Inc.
Breaking Down Revenue Trends: BeiGene, Ltd. vs ACADIA Pharmaceuticals Inc.
Breaking Down Revenue Trends: Genmab A/S vs ACADIA Pharmaceuticals Inc.
Breaking Down Revenue Trends: Bio-Techne Corporation vs ACADIA Pharmaceuticals Inc.
Revenue Insights: Sarepta Therapeutics, Inc. and Exelixis, Inc. Performance Compared
Sarepta Therapeutics, Inc. and Pharming Group N.V.: A Comprehensive Revenue Analysis
Sarepta Therapeutics, Inc. and TG Therapeutics, Inc.: A Comprehensive Revenue Analysis
Sarepta Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd.: A Comprehensive Revenue Analysis
Revenue Insights: ACADIA Pharmaceuticals Inc. and Supernus Pharmaceuticals, Inc. Performance Compared